World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
19606
World Ranking
17706
National Ranking
927

Overview

Claus Vogelmeier is affiliated with Philipp University of Marburg in Germany. The researcher's primary field of study is medicine, with a focus on pulmonary and respiratory medicine, physiology, epidemiology, public health, environmental and occupational health, and cardiology and cardiovascular medicine.

Their main topics of research cover a range of areas related to respiratory health, including:

  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Asthma and respiratory diseases
  • Respiratory support and mechanisms
  • Respiratory and cough-related research
  • Inhalation and respiratory drug delivery
  • Pulmonary hypertension research and treatments
  • Pediatric health and respiratory diseases

Vogelmeier has contributed extensively to academic journals with a notable number of publications in key respiratory medicine venues. Frequent publication venues include:

  • Pneumologie
  • International Journal of COPD
  • American Journal of Respiratory and Critical Care Medicine
  • Respiratory Research
  • Respiratory Medicine

The researcher has collaborated regularly with several co-authors, reflecting a robust network in the field. Frequent co-authors are:

  • Peter Alter
  • Rudolf A. Jörres
  • Robert Bals
  • Tobias Welte
  • Henrik Watz

Some of the most recent and significant papers associated with Vogelmeier include:

  • Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary, 2023, European Respiratory Journal
  • Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease, 2020, American Journal of Respiratory and Critical Care Medicine
  • Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary, 2023, American Journal of Respiratory and Critical Care Medicine
  • Improving lung health in low-income and middle-income countries: from challenges to solutions, 2021, The Lancet
  • Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision, 2022, American Journal of Respiratory and Critical Care Medicine

Best Publications

  • Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease

    David M G Halpin;Gerard J Criner;Alberto Papi;Dave Singh

  • Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression.

    Jürgen Behr;Konrad Maier;Barbara Degenkolb;Fritz Krombach

  • Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study.

    Claus F Vogelmeier;Eric D Bateman;John Pallante;Vijay K T Alagappan

  • Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLD

    Claus F. Vogelmeier;Gerard J. Criner;Fernando J. Martinez;Antonio R Anzueto

  • Benralizumab for the Prevention of COPD Exacerbations

    Gerard J. Criner;Bartolome R. Celli;Christopher E. Brightling;Alvar Agusti

  • European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency.

    Marc Miravitlles;Asger Dirksen;Ilaria Ferrarotti;Vladimir Koblizek

  • Improving lung health in low-income and middle-income countries: from challenges to solutions

    Jamilah Meghji;Kevin Mortimer;Alvar Agusti;Alvar Agusti;Brian W Allwood

  • Exacerbations of COPD

    Christian Viniol;Claus F. Vogelmeier

  • Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin

    C. Vogelmeier;R. Buhl;C. P. Criée;A. Gillissen

  • Goals of COPD treatment: Focus on symptoms and exacerbations.

    Claus F. Vogelmeier;Miguel Román-Rodríguez;Dave Singh;MeiLan K. Han

  • Formoterol mono- and combination therapy with tiotropium in patients with COPD: A 6-month study

    Claus Vogelmeier;Peter Kardos;Sergio Harari;Steven J.M. Gans

  • Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group.

    Andreas Elssner;Florian Jaumann;Sandra Dobmann;Jürgen Behr

  • Integrated care pathways for airway diseases (AIRWAYS-ICPs).

    J. Bousquet;A. Addis;I. Adcock;I. Agache

  • Precision medicine in airway diseases: moving to clinical practice

    Alvar Agustí;Mona Bafadhel;Richard Beasley;Elisabeth H. Bel

  • Microbial DNA induces a host defense reaction of human respiratory epithelial cells.

    Juliane Platz;Christoph Beisswenger;Alexander Dalpke;Rembert Koczulla

  • Benefits of pulmonary rehabilitation in COVID-19 – a prospective observational cohort study

    Rainer Gloeckl;Daniela Leitl;Inga Jarosch;Tessa Schneeberger

  • Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial.

    Nicolas Roche;Kenneth R Chapman;Claus F Vogelmeier;Felix J F Herth

  • A review of national guidelines for management of COPD in Europe

    Marc Miravitlles;Claus Vogelmeier;Nicolas Roche;David Halpin

  • Suppression of pulmonary innate host defence in smokers

    Herr C;Beisswenger C;Hess C;Kandler K

  • Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations

    Phuwanat Sakornsakolpat;Dmitry Prokopenko;Maxime Lamontagne;Nicola F. Reeve

Frequent Co-Authors

Roland Buhl
Roland Buhl Johannes Gutenberg University of Mainz
Tobias Welte
Tobias Welte University of Hannover
Klaus F. Rabe
Klaus F. Rabe Kiel University
Leonardo M. Fabbri
Leonardo M. Fabbri University of Ferrara
Leif Bjermer
Leif Bjermer Lund University
Jørgen Vestbo
Jørgen Vestbo University of Manchester
Alvar Agusti
Alvar Agusti University of Barcelona
François Maltais
François Maltais Université Laval
Alberto Papi
Alberto Papi University of Ferrara
Nicolas Roche
Nicolas Roche Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical fields in the USA offers a variety of career pathways, including many flexible online degree options. For those drawn to healthcare but not directly to medicine, pursuing a health information technology online degree is a great option. This program focuses on the vital role of managing healthcare data and digital records in hospitals and clinics.

Those interested in administrative roles can consider the average cost of medical billing and coding program, providing specialized skills at accessible tuition rates. Medical billing and coding professionals are in growing demand as healthcare providers rely on accurate records and insurance processing.

Nursing remains a rewarding and high-demand pathway. Many study options are now available, such as cheapest np programs online for advanced nursing careers, or foundational online nursing programs for registered nurse degrees. These online programs often allow students to balance work, life, and study on their own schedule, making them accessible nationwide.

Best Scientists Citing Claus Vogelmeier

Trending Scientists